Bloom Energy Named Techs Biggest Outperformer by Analyst Beth Kindig After 217 Rally BioAtla BCAB Q4 2025 Earnings Why the Beat Matters Inflation Accelerates as Conflict in Iran Disrupts Global Markets Childrens PLCE Q1 2026 Results Fall Short EPS 186 Revenue NA Singapore Strengthens AI Hub Status with Strategic Pacts Involving Google and OpenAI plus 234 Million Commitment Tyson Foods Q1 2026 Earnings EPS Beats Estimates Stock Edges Lower Expion360 XPON Reports Strong Q2 2025 Revenue NA EPS Beats Chunghwa Telecom CHT Holds Steady Near Support Amid Modest Decline Flight Delays at Chicago OHare and Other Airports Impact Memorial Day Weekend Travel Wingstop Shares Decline 12 as Latest Earnings Miss Analyst Expectations Exhicon Events Shares Rise Amid Broader Market Pullback Indian Government Expands Central Bank of India Stake Sale to 8 After OFS Attracts 236 Times Subscription Retail Bidding Opens Monday Asphalts Heat Island Effect Pushes Cities Toward Pavement Revolution Stellantis Turnaround Plan Prediction Market Regulation Oura IPO Filing Among Key Investor Topics in CNBC Morning Squawk Innovative Eyewear Inc LUCY Q1 2026 Earnings EPS Surprise Lifts Sentiment Despite Revenue Uncertainty SFNC Q1 2026 Earnings Slight EPS Miss Amid Stable Operations OXSQG Q1 2026 Earnings EPS Misses Estimates as Investment Income Falls Short Note Price Holds Steady PLMR Q1 2026 Earnings Palomar Holdings Beats EPS Estimates by 301 Vistagen Therapeutics VTGN Q1 2026 Earnings Narrowing Loss Beats Estimates as Pipeline Progress Continues RPC RES Slides 084 as Selling Pressure Mounts 20260520 Endava DAVA Plunges 165 as Key Support Levels Come into Focus RBC Capital Markets Adjusts IBM Price Target While Maintaining Positive Outlook IGC Pharma IGC Delivers Q1 2026 Beat EPS 002 vs 002 Expected Lightbridge Corporation Q1 2026 Earnings Net Loss of 020 Per Share as Company Advances Fuel Technology MPTI Q1 2026 Earnings EPS Beats Estimates by 113 Driving Positive Stock Reaction TeraWulf WULF in Focus Assessing LongTerm Potential Among LowPriced Stocks CLGN Q4 2025 Earnings EPS Misses Estimates as Biotech Continues PreRevenue Phase